Is Abbott Laboratories Stock Underperforming the S&P 500?

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops & manufactures a diversified line of healthcare products. Valued at $221.2 billion by market cap, Abbott’s extensive portfolio includes life-changing technologies, with leading businesses and products in diagnostics, medical devices, nutritional, and branded generic medicines.

Companies worth $200 billion or more are generally described as "mega-cap stocks." Abbott Laboratories fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the healthcare sector. Abbott employs nearly 114,000 people in more than 160 countries across the globe.